Free Trial

Hillstream BioPharma (HILS) SEC Filings & 10K Form

Hillstream BioPharma logo
$1.29 -0.08 (-5.84%)
As of 06/13/2025

Recent Hillstream BioPharma SEC Filings

DateFilerForm TypeView
06/11/2025
4:29 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
3:39 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
1:31 PM
GSB Holdings, Inc. (Filed by)
Hillstream BioPharma (Subject)
Tharimmune, Inc. (Subject)
Form SCHEDULE 13G
05/12/2025
7:00 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
9:28 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form ARS
04/30/2025
4:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form DEFA14A
04/30/2025
4:00 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form DEF 14A
04/28/2025
4:26 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
6:35 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2025
3:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
4:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
6:00 PM
Kim Dong (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2025
7:12 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/14/2025
3:47 PM
MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:38 PM
Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 424B3
12/26/2024
11:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form EFFECT
12/20/2024
7:00 PM
MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/17/2024
3:30 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
12/06/2024
4:25 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
3:00 PM
Parikh Sanam (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/21/2024
3:51 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:06 PM
Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
4:22 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2024
3:15 PM
MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
8:58 AM
Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4/A
10/08/2024
3:10 PM
Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
9:00 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
8:06 AM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:17 PM
MILBY RANDY (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:17 PM
Bui Lynne A. (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:18 PM
Mazur Leonard L (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:18 PM
Appajosyula Sireesh (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:18 PM
Anderson Kelly (Reporting)
Hillstream BioPharma (Issuer)
Tharimmune, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
2:09 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
3:13 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 424B3
07/21/2024
11:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form EFFECT
07/15/2024
3:43 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/28/2024
4:25 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
06/20/2024
3:15 PM
Hillstream BioPharma (Filer)
Tharimmune, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HILS) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners